Home
Finance
Bank Routing Numbers
FedWire
Stock Portfolio Generator
Technical Analysis of Stocks
Best Months to Buy or Sell Stocks
Games
Hangman - Hang 'Em High
Chess
Shuttles Game
Chemistry
Chemical Equation Balancer
Periodic Table of the Elements
Chemical Bond Polarity Calculator
Linear Algebra
Gauss-Jordan Elimination Calculator
Calculate Pivots
Factorize: A=LU
Inverse Matrix Calculator
Null Space Calculator
Column Space Calculator
Row Space Calculator
Multiply Two Matrices
AI
Genetic Algorithms
Genetic Algorithms Stock Portfolio Generator
Shuttles Game
Tic-Tac-Toe Game
Personality Profile
Checkers Game
Scripts
Scan for all machines running IIS in a domain
Extract data from a Microsoft Word document
Outlook Scripts
Excel Scripts
IT
How to Stop a DDOS Attack
Subnet Calculator
Fingerprint Web Server
Whois Lookup
InternetPeriscope
About
My Favorite Links
Resume
View My Profile on LinkedIn
View My Profile on DataCamp
View My Profile on Pluralsight
Back to Companies who have applied for FDA Drug Approval
FDA Drug Approval Applications Sponsored by ROCHE
Application Number
Drugs/Products
Application Type
Most Recent Label Available Flag
Current Patent Flag
Action Type
Chemical Type
Ther Potential
Orphan Code
003718
SYNKAYVITE
New Drug Application
Approval
006071
BEROCCA PN
New Drug Application
Approval
006525
GANTRISIN
New Drug Application
Approval
006917
GANTRISIN
New Drug Application
Approval
007757
GANTRISIN
New Drug Application
Approval
New manufacturer
(S) Standard review drug
008414
GANTRISIN
New Drug Application
Approval
New ester, new salt, or other noncovalent derivative
(S) Standard review drug
008420
RIMIFON
New Drug Application
Approval
New manufacturer
(S) Standard review drug
008983
ARFONAD
New Drug Application
Approval
New molecular entity (NME)
(P) Priority review drug
009182
GANTRISIN
GANTRISIN PEDIATRIC
LIPO GANTRISIN
New Drug Application
Approval
New ester, new salt, or other noncovalent derivative
(S) Standard review drug
009660
NOLUDAR
New Drug Application
Approval
New molecular entity (NME)
(S) Standard review drug
010355
QUARZAN
New Drug Application
Approval
New molecular entity (NME)
(S) Standard review drug
010423
LORFAN
New Drug Application
Approval
New molecular entity (NME)
(S) Standard review drug
011745
KONAKION
New Drug Application
Approval
New manufacturer
(S) Standard review drug
012486
TARACTAN
New Drug Application
Approval
New molecular entity (NME)
(S) Standard review drug
012487
TARACTAN
New Drug Application
Approval
New formulation
(S) Standard review drug
012715
GANTANOL
GANTANOL-DS
New Drug Application
Approval
New molecular entity (NME)
(S) Standard review drug
013263
VALIUM
New Drug Application
Approval
New molecular entity (NME)
(S) Standard review drug
013294
AZO GANTANOL
New Drug Application
Approval
New combination
(S) Standard review drug
013664
GANTANOL
New Drug Application
Approval
New manufacturer
(S) Standard review drug
014740
MENRIUM 10-4
MENRIUM 5-2
MENRIUM 5-4
New Drug Application
Approval
New combination
(S) Standard review drug
016087
VALIUM
New Drug Application
Approval
New formulation
(S) Standard review drug
016149
TARACTAN
New Drug Application
Approval
New formulation
(S) Standard review drug
016912
LARODOPA
New Drug Application
Approval
New molecular entity (NME)
(P) Priority review drug
017533
KLONOPIN
New Drug Application
Approval
New molecular entity (NME)
(P) Priority review drug
017546
NIPRIDE
New Drug Application
Approval
New molecular entity (NME)
(P) Priority review drug
017589
SOLATENE
New Drug Application
Approval
New molecular entity (NME)
(P) Priority review drug
017952
TRIMPEX
TRIMPEX 200
New Drug Application
Approval
New manufacturer
(S) Standard review drug
018179
VALRELEASE
New Drug Application
Approval
New formulation
(S) Standard review drug
018550
RIMADYL
New Drug Application
Approval
New molecular entity (NME)
(S) Standard review drug
018557
FANSIDAR
New Drug Application
Approval
New molecular entity (NME); New combination
(P) Priority review drug
019358
AZO GANTRISIN
New Drug Application
Approval
New indication
(S) Standard review drug
019369
TEGISON
New Drug Application
Approval
New molecular entity (NME)
(P) Priority review drug
019591
LARIAM
New Drug Application
Approval
New manufacturer
(S) Standard review drug
(V) Orphan drug
020137
DEMADEX
New Drug Application
Approval
New formulation
(S) Standard review drug
020199
HIVID
New Drug Application
Approval
New molecular entity (NME)
(P*) Priority review drug*
(V) Orphan drug
020239
KYTRIL
New Drug Application
Approval
New molecular entity (NME)
(S) Standard review drug
020305
KYTRIL
New Drug Application
Approval
New formulation
(S) Standard review drug
020438
VESANOID
New Drug Application
Approval
New formulation
(P) Priority review drug
(V) Orphan drug
020813
KLONOPIN RAPIDLY DISINTEGRATING
New Drug Application
Approval
New formulation
(S) Standard review drug
020942
VERSED
New Drug Application
Approval
New formulation
(P) Priority review drug
021087
TAMIFLU
New Drug Application
Approval
New molecular entity (NME)
(P) Priority review drug
021238
KYTRIL
New Drug Application
Approval
New formulation
(S) Standard review drug
021246
TAMIFLU
New Drug Application
Approval
New formulation
(P) Priority review drug
021481
FUZEON
New Drug Application
Approval
New molecular entity (NME)
(P) Priority review drug
021511
COPEGUS
New Drug Application
Approval
New formulation
(P) Priority review drug
021858
BONIVA
New Drug Application
Approval
New formulation
(S) Standard review drug
050565
COACTIN
New Drug Application
Approval
New molecular entity (NME)
(S) Standard review drug
062510
ROCEPHIN
Abbreviated New Drug Application
Approval
083639
ENDEP
Abbreviated New Drug Application
Approval
085303
ENDEP
Abbreviated New Drug Application
Approval
085749
ENDEP
Abbreviated New Drug Application
Approval
Back to Companies who have applied for FDA Drug Approval